10. ENVAST BROCHURE
Product brochure enVast to be used as leave behind piece as needed.
Vesalio announces oversubscribed Class A financing
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round.
12. Vesalio Micro Flow Model IFU
Flow model set up and breakdown pdf for viewing.
Vesalio Announces Completion of Enrollment in its FDA Enabling Stroke Study
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke.
Vesalio Announces Earl Slee as New Board Observer and Senior Advisor to the Company
As a board observer and senior advisor to the company, Earl Slee brings extensive medical device innovation and business development expertise.
Vesalio Announces Appointment of Mike Kujak as its New Independent Board Chairman
As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the medical device start-up space.
Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI
Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.
10. VESALIO NEVA BRANDING RESOURCES
Brand guidelines to show the Vesalio brand is to be used and presented to the public.
09. Field Report
Report template for case feedback. Can also be used for complaints reporting.
07. Micro Catheter Considerations
Recommendations on microcatheters and frequently asked questions on microcatheter use with NeVa